Plexus (NASDAQ:PLXS) Price Target Raised to $195.00 at Benchmark

Plexus (NASDAQ:PLXS) had its target price hoisted by Benchmark from $165.00 to $195.00 in a report issued on Wednesday morning, Marketbeat.com reports. Benchmark currently has a buy rating on the technology company’s stock.

Several other equities analysts have also recently issued reports on PLXS. Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a research note on Thursday, January 22nd. Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price target on the stock. in a research note on Friday, October 24th. Needham & Company LLC raised their price objective on shares of Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Stifel Nicolaus set a $150.00 price objective on Plexus in a report on Friday, October 24th. Finally, Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Plexus presently has a consensus rating of “Hold” and an average price target of $171.00.

Plexus Stock Up 4.2%

Plexus stock opened at $180.85 on Wednesday. The stock has a 50 day moving average of $157.46 and a two-hundred day moving average of $145.04. Plexus has a twelve month low of $103.43 and a twelve month high of $186.47. The stock has a market capitalization of $4.84 billion, a price-to-earnings ratio of 28.89 and a beta of 0.81. The company has a current ratio of 1.58, a quick ratio of 0.77 and a debt-to-equity ratio of 0.06.

Insider Activity at Plexus

In other Plexus news, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $144.93, for a total value of $195,220.71. Following the completion of the transaction, the chief accounting officer directly owned 21,544 shares of the company’s stock, valued at approximately $3,122,371.92. This trade represents a 5.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $143.47, for a total value of $71,735.00. Following the sale, the director directly owned 7,665 shares in the company, valued at $1,099,697.55. This trade represents a 6.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 9,674 shares of company stock valued at $1,382,876 in the last ninety days. Company insiders own 1.78% of the company’s stock.

Institutional Trading of Plexus

Several large investors have recently bought and sold shares of the company. Salomon & Ludwin LLC acquired a new position in shares of Plexus during the 3rd quarter worth $30,000. Allworth Financial LP raised its position in Plexus by 70.1% during the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after acquiring an additional 103 shares during the last quarter. Huntington National Bank lifted its holdings in shares of Plexus by 41.5% in the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after purchasing an additional 95 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Plexus in the third quarter valued at about $72,000. Finally, CWM LLC grew its position in shares of Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after purchasing an additional 213 shares during the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Key Stories Impacting Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Raised Q2 guidance: Plexus set Q2 fiscal 2026 non‑GAAP EPS guidance of $1.80–$1.95 (GAAP $1.53–$1.68) and revenue guidance of $1.110–$1.150B, above Street expectations — this underpins near-term revenue/earnings visibility. Quiver Quant: Q1 results & guidance
• Positive Sentiment: Solid demand and program wins: Q1 revenue was $1.07B (+10% YoY) and management won 22 new manufacturing programs with $283M of annualized revenue potential, supporting future ramps. GlobeNewswire: Q1 release
• Positive Sentiment: Share repurchase activity: The company repurchased $22.4M of stock in Q1 and has ~$62.6M remaining under the $100M authorization, which supports EPS and capital return. GlobeNewswire: repurchase details
• Positive Sentiment: Analyst upgrade/price target lift: Benchmark raised its price target to $195 and reiterated a Buy, adding institutional validation to the beat/guidance. The Fly: Benchmark raise
• Neutral Sentiment: Earnings beat was slight and revenue roughly in line: Non‑GAAP EPS $1.78 beat consensus by $0.01 and revenue matched estimates, so the beat is modest rather than a blowout. Zacks: EPS beat
• Negative Sentiment: Negative free cash flow and working capital draws: Q1 showed -$50.6M free cash flow and a longer cash cycle (69 days) driven by higher inventory and program ramps, which could pressure near-term liquidity. Quiver Quant: cash flow details
• Negative Sentiment: Sequential GAAP EPS decline and customer concentration: GAAP diluted EPS fell sequentially (Q1 GAAP $1.51 vs. prior quarter $1.87) and top-10 customers represent ~52% of revenue, increasing exposure to a few large accounts. GlobeNewswire: financials
• Negative Sentiment: Insider selling noted: Recent data shows multiple insider sales across senior executives, which some investors view as a governance/offset risk to management conviction. Quiver Quant: insider activity

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.